Carcinoma News and Research

RSS
Carcinoma is cancer that begins in the skin or in tissues that line or cover internal organs.
Possible alternative to biopsy discovered for renal cancer diagnosis

Possible alternative to biopsy discovered for renal cancer diagnosis

Early PBC prognosis advocated

Early PBC prognosis advocated

MicroRNAs hold promise as markers for bladder cancer prognosis

MicroRNAs hold promise as markers for bladder cancer prognosis

Selumetinib shrinks tumors in women with low-grade ovarian cancer

Selumetinib shrinks tumors in women with low-grade ovarian cancer

Tivozanib overall survival results announced by AVEO and Astellas

Tivozanib overall survival results announced by AVEO and Astellas

Metastatic renal cell carcinoma (mRCC) therapy: an interview with Charles A. Nicolette, Ph.D., CSO of Argos Therapeutics

Metastatic renal cell carcinoma (mRCC) therapy: an interview with Charles A. Nicolette, Ph.D., CSO of Argos Therapeutics

Researchers identify miR-506 as potential therapeutic candidate for metastatic ovarian cancer

Researchers identify miR-506 as potential therapeutic candidate for metastatic ovarian cancer

Case Western Reserve receives $220,000 grant to study gastric cancers

Case Western Reserve receives $220,000 grant to study gastric cancers

Sunitinib does not cause lingering risks for cancer patients after their treatment ends

Sunitinib does not cause lingering risks for cancer patients after their treatment ends

Sunitinib shows promise against metastatic renal cell carcinoma

Sunitinib shows promise against metastatic renal cell carcinoma

Scientists discover recurring pattern of more than 13,000 epigenetic alterations in young tumours

Scientists discover recurring pattern of more than 13,000 epigenetic alterations in young tumours

Positive results from NCI-sponsored bevacizumab trial on cervical cancer

Positive results from NCI-sponsored bevacizumab trial on cervical cancer

Positive data from Oncolytics' REOLYSIN Phase 2 combination trial on SCCLC

Positive data from Oncolytics' REOLYSIN Phase 2 combination trial on SCCLC

Genomic Health fourth quarter total revenue increases to $60.4 million

Genomic Health fourth quarter total revenue increases to $60.4 million

Surgery could boost chemotherapy outcomes in canine TCC

Surgery could boost chemotherapy outcomes in canine TCC

Acceleron commences dalantercept phase 2 study in metastatic renal cell carcinoma

Acceleron commences dalantercept phase 2 study in metastatic renal cell carcinoma

Previously poorly investigated signalling pathway crucial for proliferation of prostate cancer cells

Previously poorly investigated signalling pathway crucial for proliferation of prostate cancer cells

Acceleron Pharma initiates dalantercept phase 2 study in advanced ovarian cancer

Acceleron Pharma initiates dalantercept phase 2 study in advanced ovarian cancer

Subclinical hypothyroidism not prognostic in thyroid carcinoma

Subclinical hypothyroidism not prognostic in thyroid carcinoma

Interferon retreatment warning in HCV

Interferon retreatment warning in HCV

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.